Physician

Benjamin Silverman, D.O.

According to 2025 Medicare claims, Benjamin Silverman, D.O. (NPI: 1699091090) practices cardiology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (NPI: 1124122387; TIN: 232865181) and primary practice location at 08360-5843. Silverman is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Silverman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,210 traditional Medicare patients, billed 5,945 HCPCS/CPT codes, and received $328,137 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,858 prescription claims across 816 beneficiaries totaling $1,088,329 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 4 records totaling $69. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $117,992 to $328,137. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,401 to $1,088,329. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	809	2,301	$117,992
2016	757	2,239	$140,809
2017	663	1,990	$121,282
2018	1,796	6,521	$421,923
2019	1,583	5,988	$383,426
2020	1,148	4,490	$301,568
2021	1,126	4,962	$349,343
2022	1,166	5,439	$380,185
2023	1,226	5,710	$353,477
2024	1,210	5,945	$328,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	837	$26,401
2016	151	1,128	$42,418
2017	182	1,743	$109,804
2018	463	2,198	$110,096
2019	517	3,433	$261,561
2020	537	4,142	$363,251
2021	598	4,722	$512,785
2022	671	5,620	$718,114
2023	742	6,164	$858,105
2024	816	6,858	$1,088,329

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	422	437	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	521	1,000	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	382	563	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	569	1,109	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	523	649	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	446	25,743	$486,446
Xarelto	Rivaroxaban	141	9,643	$170,518
Entresto	Sacubitril/Valsartan	80	4,703	$105,157
Repatha Sureclick	Evolocumab	75	3,500	$65,711
Farxiga	Dapagliflozin Propanediol	39	2,290	$42,525

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$69	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Silverman, D.O.?

Tedicare shows public-source Medicare data for Benjamin Silverman, D.O. (NPI 1699091090), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Silverman, D.O. have ACO affiliation data?

Benjamin Silverman, D.O. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Benjamin Silverman, D.O.?

Benjamin Silverman, D.O. is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (billing NPI 1124122387) in the available physician profile data.

Does Benjamin Silverman, D.O. have Open Payments data?

Benjamin Silverman, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.